found that inhibiting RBM17 expression can significantly reduce the proliferation of hypopharyngeal carcinoma cells, promote their apoptosis, and block their cell cycle progression at the G2/M phase (27). Here, RBM17 is linked to hypopharyngeal carcinoma.